Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levobupivacaine

K J McClellan1, C M Spencer

  • 1Adis International Limited, Auckland, New Zealand. demail@adis.co.nz

Drugs
|October 20, 1998
PubMed
Summary
This summary is machine-generated.

Levobupivacaine, a safer alternative to bupivacaine, demonstrates reduced cardiotoxicity and central nervous system effects. Clinical studies confirm its comparable efficacy and safety for surgical and labor anesthesia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-grain scintillator screens for proton radiography.

The Review of scientific instruments·2024
Same author

Kondo quasiparticle dynamics observed by resonant inelastic x-ray scattering.

Nature communications·2022
Same author

Physics-informed machine learning for inorganic scintillator discovery.

The Journal of chemical physics·2018
Same author

Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

CNS drugs·2016
Same author

Quetiapine : A Review of its Use in Schizophrenia.

CNS drugs·2016
Same author

Quantum critical fluctuations in the heavy fermion compound Ce(Ni0.935Pd0.065)₂Ge₂.

Journal of physics. Condensed matter : an Institute of Physics journal·2014
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Bupivacaine, a widely used local anesthetic, carries a risk of fatal cardiotoxicity.
  • Levobupivacaine is an enantiomer of bupivacaine, developed to mitigate these risks.

Purpose of the Study:

  • To compare the safety and efficacy of levobupivacaine with bupivacaine.
  • To evaluate the cardiotoxic and central nervous system effects of levobupivacaine.

Main Methods:

  • Studies involved healthy volunteers and patients undergoing surgery or labor.
  • Evaluated arrhythmogenicity, QT interval, QRS duration, and CNS depressant effects.
  • Clinical trials assessed sensory and motor block characteristics and adverse events.

Main Results:

  • Levobupivacaine showed significantly weaker arrhythmogenic effects and weaker effects on QT interval and QRS duration compared to bupivacaine.

Related Experiment Videos

  • Intravenous levobupivacaine exhibited less CNS depression than bupivacaine.
  • Epidural levobupivacaine provided clinically similar sensory and motor blocks to bupivacaine, with longer duration at higher concentrations.
  • Levobupivacaine 0.25% was as effective as bupivacaine 0.25% for labor analgesia.
  • Intraoperative hypotension was the most common adverse event; no serious arrhythmias occurred.

    • Conclusions:

    • Levobupivacaine offers a favorable safety profile with reduced cardiotoxicity and CNS effects compared to bupivacaine.
    • It provides comparable efficacy to bupivacaine for surgical anesthesia and labor analgesia.
    • Levobupivacaine is a well-tolerated and effective local anesthetic option.